Back

Desjardins RI USA - Net-Zero Emissions Pathway ETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison

Sell

DRMU.TO
Desjardins RI USA - Net-Zero Emissions Pathway ETF

Last Price:

$49.63

Seasonality Move:

6.74%

Buy

DRUG
Bright Minds Biosciences, Inc.

Last Price:

$78.95

Seasonality Move:

-32.16%

Sell

Desjardins RI USA - Net-Zero Emissions Pathway ETF (DRMU.TO) is a Sell

Is Desjardins RI USA - Net-Zero Emissions Pathway ETF a Buy, Sell or Hold?

The current Desjardins RI USA - Net-Zero Emissions Pathway ETF [DRMU.TO] share price is $49.17. The Score for DRMU.TO is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
DRMU.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

Bright Minds Biosciences, Inc. (DRUG) is a Buy

Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?

The current Bright Minds Biosciences, Inc. [DRUG] share price is $88.08. The Score for DRUG is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
DRUG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DRMU.TO Stock Price Chart

What is Desjardins RI USA - Net-Zero Emissions Pathway ETF's stock price today?

The Desjardins RI USA - Net-Zero Emissions Pathway ETF share price today is $49.17

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRMU.TO is experiencing selling pressure, which indicates risk of future bearish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences, Inc.'s stock price today?

The Bright Minds Biosciences, Inc. share price today is $88.08

The current trend is moderately bullish and DRUG is experiencing slight selling pressure.

DRMU.TO Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.13	Sell
Relative Strength Index (14 RSI):	34.81	Sell
Chaikin Money Flow:	-292	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(49.58 - 50.74)	Sell
Bollinger Bands (100):	(47.59 - 50.55)	Buy

DRUG Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	7.77	Buy
Relative Strength Index (14 RSI):	66.44	Buy
Chaikin Money Flow:	-23974	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(59.51 - 82.89)	Buy
Bollinger Bands (100):	(41.26 - 68.88)	Buy

DRMU.TO Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	50.04	Sell
20-day SMA:	50.27	Sell
50-day SMA:	50.26	Sell
200-day SMA:	46.04	Buy
8-day EMA:	49.91	Sell
20-day EMA:	50.17	Sell
50-day EMA:	49.94	Sell
200-day EMA:	47.1	Buy

DRUG Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	85.48	Buy
20-day SMA:	74.4	Buy
50-day SMA:	65.57	Buy
200-day SMA:	42.82	Buy
8-day EMA:	85.2	Buy
20-day EMA:	77.09	Buy
50-day EMA:	66.93	Buy
200-day EMA:	47.3	Buy

Desjardins RI USA - Net-Zero Emissions Pathway ETF Earnings Growth & DRMU.TO Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.

Desjardins RI USA - Net-Zero Emissions Pathway ETF Technical Analysis

	Dec 4	Dec 5	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16	Dec 17
	Dec
	04	05	08	09	10	11	12	15	16	17
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences, Inc. Technical Analysis

	Dec 4	Dec 5	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16	Dec 17
	Dec
	04	05	08	09	10	11	12	15	16	17
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):